Dr. Gulseth's extensvie expertise in the management of drugs like warfarin, enoxaparin, heparin, argatroban, rivaroxaban, dabigatran etexilate, edoxaban and apixaban, combined with past litigation work, make him an ideal expert witness. Dr. Gulseth recently chaired the panel who has recently written the most authoritative guidelines on how to assure the safety of anticoagulation therapy: http://www.ismp.org/selfassessments/Antithrombotic/2017/Default.aspx Contact him at mgulseth@anticoagulationconsulting.com for further details.